OPPORTUNITIES OF DORNASE ALFA IN PEDIATRICS

<em>Early treatment with Pulmozyme (dornase alfa) and its prolonged use in combination with basis therapy results in decrease of exacerbation rate, prolongation of remission of bronchopulmonary process with normal ventilation functions of lungs and gives patients with cystic fibrosis an opport...

Full description

Bibliographic Details
Main Author: O.I. Simonova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2011-01-01
Series:Вопросы современной педиатрии
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/659